5AR1 Stock Chart & Stats
€0.24
-€0.07(-21.17%)
At close: 4:00 PM EDT
€0.24
-€0.07(-21.17%)
Day’s Range― - ―
52-Week Range€0.24 - €7.40
Previous CloseN/A
Volume0.00
Average Volume (3M)796.00
Market Cap
€49.29M
Enterprise Value€185.74
Total Cash (Recent Filing)€6.22M
Total Debt (Recent Filing)€15.37M
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Mar 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.54
Shares Outstanding139,836,520
10 Day Avg. Volume360
30 Day Avg. Volume796
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.06
Price to Sales (P/S)2.58
P/FCF Ratio-0.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.51
Revenue Forecast (FY)€30.32M
Bulls Say, Bears Say
Bulls Say
Strengthened Balance SheetThe dramatic 2025 increase in equity and assets materially improves solvency optics and provides a durable capital buffer against operating volatility. A stronger balance sheet supports strategic options, reduces immediate default risk, and underpins funding flexibility over the next several months.
WLFI Token LiquidityLarge transferable WLFI holdings create structural liquidity optionality—collateral, staking, or lending—that materially mitigates prior going-concern concerns. This asset base offers sustainable flexibility to fund operations or pursue initiatives without relying solely on dilutive equity issuance.
Divestiture Provides Secured ConsiderationSelling ALT 5 Sigma Canada converted a non-core asset into a secured creditor claim and equity upside in the buyer. The transaction structurally improves liquidity and focus, reducing operating complexity while preserving potential recoveries tied to the buyer's future financings.
Bears Say
Large Net LossesExtremely large net losses erode capital and limit the company's ability to generate sustainable earnings. Persistently negative profitability forces reliance on balance-sheet actions or outside financing, raising execution risk and undermining long-term operational stability over the coming months.
Weak Cash GenerationDeeply negative free cash flow and a return to negative operating cash flow indicate structural cash burn. This reduces financing optionality, increases reliance on asset monetization or external capital, and heightens dilution or leverage risk absent durable improvement in cash generation.
Nasdaq Listing RiskNon-compliance with Nasdaq's bid-price standard threatens the company's listing status, which would materially reduce liquidity, investor access, and ability to raise capital. Listing pressure may force structural remedies (reverse split, consolidation) that affect shareholder base and financing options.
AI Financial Corporation News
5AR1 FAQ
What was AI Financial Corporation’s price range in the past 12 months?
AI Financial Corporation lowest stock price was €0.24 and its highest was €7.40 in the past 12 months.
What is AI Financial Corporation’s market cap?
AI Financial Corporation’s market cap is €49.29M.
When is AI Financial Corporation’s upcoming earnings report date?
AI Financial Corporation’s upcoming earnings report date is Mar 26, 2027 which is in 222 days.
How were AI Financial Corporation’s earnings last quarter?
Currently, no data Available
Is AI Financial Corporation overvalued?
According to Wall Street analysts AI Financial Corporation’s price is currently Overvalued.
Does AI Financial Corporation pay dividends?
AI Financial Corporation does not currently pay dividends.
What is AI Financial Corporation’s EPS estimate?
AI Financial Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AI Financial Corporation have?
AI Financial Corporation has 139,836,520 shares outstanding.
What happened to AI Financial Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AI Financial Corporation?
Currently, no hedge funds are holding shares in DE:5AR1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AI Financial Corporation Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:5AR1 Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-94.39%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1130.15%
Trailing 12-Months
Company Description
AI Financial Corporation
AI Financial Corporation, a global entity operating through its various subsidiaries, specializes in distributed ledger technology solutions. The company's activities are strategically divided into two primary segments: Fintech and Biotechnology. Its Fintech division manages the entire ecosystem of digital assets, covering everything from their initial creation (tokenization) to their trading, clearing, settlement, payment processing, and secure safekeeping. Within this sector, AI Financial offers significant products such as ALT 5 Prime, a sophisticated electronic over-the-counter (OTC) trading platform designed for the acquisition and divestiture of digital assets. Another key offering is ALT 5 Pay, a cryptocurrency payment gateway that empowers merchants to either accept and disburse payments in digital currencies directly or integrate this capability into their existing software applications. The biotechnology arm is dedicated to identifying, procuring, licensing, advancing, collaborating on, and commercializing innovative, non-opioid, and non-addictive therapeutic solutions for addressing pain and addiction. Noteworthy projects include JAN 101, an orally administered, sustained-release sodium nitrite compound that has successfully concluded Phase 2a clinical trials for the treatment of peripheral arterial disease and pain. Additionally, the company is developing JAN123, a low-dose naltrexone formulation specifically tailored for managing chronic regional pain syndrome. Established in 1976, the company is based in Las Vegas, Nevada. It officially adopted its current name, AI Financial Corporation, in April 2026, having previously been known as ALT5 Sigma Corporation.